Harvard Apparatus Regenerative Technology Inc. announced that it has entered into Securities Purchase Agreements with certain investors to issue an aggregate of 367,767 shares of common stock at a purchase price of $4.03 per share for the gross proceeds of $1,482,101.01 on April 15, 2024. The shares are issued without registration under the Securities Act in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as transactions not involving a public offering and Rule 506 promulgated under and/or Regulation D thereunder.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 USD | +3.02% | +3.02% | -52.10% |
1st Jan change | Capi. | |
---|---|---|
-52.10% | 34.21M | |
+7.48% | 217B | |
+6.54% | 183B | |
+9.68% | 131B | |
+23.68% | 106B | |
-0.95% | 62.16B | |
+9.81% | 51.02B | |
+4.81% | 50.89B | |
-1.31% | 40.16B | |
+0.05% | 34.79B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding